Article

It Looks Like HGH Really Does Improve Performance

Dr. Pullen examines the use of human growth hormone's ability to improve performance in the same week that Floyd Landis admits to doping and accuses Lance Armstrong of doing the same.

This article originally appeared online at DrPullen.com.

Until now, there has really been no valid research showing whether the Human Growth Hormone that we read so much about in the sports news recently really helps athletes achieve better performance. In the Annals of Internal Medicine, a recent article shows that in trained recreational athletes there is in fact a transient improvement in sprint performance in both men and women using HGH. The improvement is even greater when combined with testosterone in male athletes.

An 8 week course of HGH improves sprint performance by almost 4% in both men and women, and when combined with testosterone improved sprint performance in men by about 8%. This benefit was lost after a 6 week “wash-out” period. Though this may seem minor, the authors suggest that a 4% difference in time in a world class sprint event is the difference between first place and last place. There was insufficient data in the study to comment on long term adverse effects of the treatment. Anti-doping efforts in HGH detection are suboptimal, so this is likely to remain a popular performance improving drug in athletes.

Ed Pullen, MD, is a board-certified family physician practicing in Puyallup, WA. He blogs at DrPullen.com — A Medical Bog for the Informed Patient.

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.